The Role of Vimentin as a Methylation Biomarker for Early Diagnosis of Cervical Cancer
Open Access
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Molecules and Cells
- Vol. 31 (5) , 405-412
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The role of hLHX6-HMR as a methylation biomarker for early diagnosis of cervical cancerOncology Reports, 2010
- Frequent methylation of Vimentin in well-differentiated gastric carcinoma.2009
- Novel functions of vimentin in cell adhesion, migration, and signalingExperimental Cell Research, 2007
- Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?Nature Reviews Cancer, 2006
- Detection and interpretation of altered methylation patterns in cancer cellsNature Reviews Cancer, 2005
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Association of Vimentin overexpression and hepatocellular carcinoma metastasisOncogene, 2004
- MethPrimer: designing primers for methylation PCRsBioinformatics, 2002
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridizationVirology, 1992